Skip to content
Research Article Open access CC BY 4.0

Seven Year Survival After Multiple Recurrences and Repeated Metastasectomies with Targeted Therapies for Renal Cell Carcinoma

Erkan Arpaci, Selcuk Ergen, Yasemin Bakkal Temi, Burak Bahadir, Huseyin Engin

International Journal of Medical and Pharmaceutical Case Reports · pp. 1–6 · Published 20 Oct 2015

10.9734/IJMPCR/2016/21419

Abstract

Background: In spite of resistance and limited response to chemotherapy, radiotherapy and immunotherapy, recent advances led to several targeted agents that showed the prolongation of progressive free survival. Due to these facts, surgical resection of multiple recurrences may be worthwhile in selected patients with kidney cancer.   Case Report: We report a case of a 47-year-old man who underwent nephrectomy for T4N0 RCC, clear cell type, Fuhrman grade 2/4 in 2007. The patient afterward had multiple tumor recurrences. He underwent four metastasectomies, including liver, skin, rectum and scalp. And he received immunotherapy and multiple lines biological targeted treatments. He remains stable for 7 years after initial diagnosis. Conclusion: In patients with metastatic RCC, recurrent resections can be achieved safely and giving biological drugs may prolong survival. Close follow-up is important for the early detection of recurrence and complete resection of metastases can improve the outcomes of patients.

Renal cell carcinoma metastasis targeted therapies.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.